Oruka Therapeutics, Inc. ORKA Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s debt securities, available-for-sale, accumulated gross unrealized loss, before tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s debt securities, available-for-sale, accumulated gross unrealized loss, before tax?
- Oruka Therapeutics, Inc. (ORKA) reported debt securities, available-for-sale, accumulated gross unrealized loss, before tax of $553K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s debt securities, available-for-sale, accumulated gross unrealized loss, before tax changed year-over-year?
- Oruka Therapeutics, Inc.'s debt securities, available-for-sale, accumulated gross unrealized loss, before tax increased by 1102.2% year-over-year, from $46K to $553K.